The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cancer Diagnostics Device-Global Market Insights and Sales Trends 2024
Synopsis
Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage.
The global Cancer Diagnostics Device market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cancer Diagnostics Device in various end use industries. The expanding demands from the Lung, Breast, Colorectal and Prostate, are propelling Cancer Diagnostics Device market. Companion Diagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Molecular Diagnostics segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cancer Diagnostics Device, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cancer Diagnostics Device market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cancer Diagnostics Device market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cancer Diagnostics Device sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cancer Diagnostics Device covered in this report include Abbott Diagnostics, Agilent Technologies, BD, bioMérieux, Qiagen and Roche Diagnostics, etc.
The global Cancer Diagnostics Device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Diagnostics
Agilent Technologies
BD
bioMérieux
Qiagen
Roche Diagnostics
Global Cancer Diagnostics Device market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cancer Diagnostics Device market, Segment by Type:
Companion Diagnostics
Molecular Diagnostics
Global Cancer Diagnostics Device market, by Application
Lung
Breast
Colorectal
Prostate
Cervical
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Cancer Diagnostics Device manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Cancer Diagnostics Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage.
The global Cancer Diagnostics Device market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cancer Diagnostics Device in various end use industries. The expanding demands from the Lung, Breast, Colorectal and Prostate, are propelling Cancer Diagnostics Device market. Companion Diagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Molecular Diagnostics segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cancer Diagnostics Device, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cancer Diagnostics Device market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cancer Diagnostics Device market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cancer Diagnostics Device sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cancer Diagnostics Device covered in this report include Abbott Diagnostics, Agilent Technologies, BD, bioMérieux, Qiagen and Roche Diagnostics, etc.
The global Cancer Diagnostics Device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Diagnostics
Agilent Technologies
BD
bioMérieux
Qiagen
Roche Diagnostics
Global Cancer Diagnostics Device market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cancer Diagnostics Device market, Segment by Type:
Companion Diagnostics
Molecular Diagnostics
Global Cancer Diagnostics Device market, by Application
Lung
Breast
Colorectal
Prostate
Cervical
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Cancer Diagnostics Device manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Cancer Diagnostics Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Cancer Diagnostics Device Market Overview
1.1 Cancer Diagnostics Device Product Overview
1.2 Cancer Diagnostics Device Market Segment by Type
1.2.1 Companion Diagnostics
1.2.2 Molecular Diagnostics
1.3 Global Cancer Diagnostics Device Market Size by Type
1.3.1 Global Cancer Diagnostics Device Market Size Overview by Type (2018-2029)
1.3.2 Global Cancer Diagnostics Device Historic Market Size Review by Type (2018-2023)
1.3.3 Global Cancer Diagnostics Device Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Cancer Diagnostics Device Sales Breakdown by Type (2018-2023)
1.4.2 Europe Cancer Diagnostics Device Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Cancer Diagnostics Device Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Cancer Diagnostics Device Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Cancer Diagnostics Device Sales Breakdown by Type (2018-2023)
2 Global Cancer Diagnostics Device Market Competition by Company
2.1 Global Top Players by Cancer Diagnostics Device Sales (2018-2023)
2.2 Global Top Players by Cancer Diagnostics Device Revenue (2018-2023)
2.3 Global Top Players by Cancer Diagnostics Device Price (2018-2023)
2.4 Global Top Manufacturers Cancer Diagnostics Device Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cancer Diagnostics Device Market Competitive Situation and Trends
2.5.1 Cancer Diagnostics Device Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Cancer Diagnostics Device Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Diagnostics Device as of 2022)
2.7 Date of Key Manufacturers Enter into Cancer Diagnostics Device Market
2.8 Key Manufacturers Cancer Diagnostics Device Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Cancer Diagnostics Device Status and Outlook by Region
3.1 Global Cancer Diagnostics Device Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Cancer Diagnostics Device Historic Market Size by Region
3.2.1 Global Cancer Diagnostics Device Sales in Volume by Region (2018-2023)
3.2.2 Global Cancer Diagnostics Device Sales in Value by Region (2018-2023)
3.2.3 Global Cancer Diagnostics Device Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Cancer Diagnostics Device Forecasted Market Size by Region
3.3.1 Global Cancer Diagnostics Device Sales in Volume by Region (2024-2029)
3.3.2 Global Cancer Diagnostics Device Sales in Value by Region (2024-2029)
3.3.3 Global Cancer Diagnostics Device Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Cancer Diagnostics Device by Application
4.1 Cancer Diagnostics Device Market Segment by Application
4.1.1 Lung
4.1.2 Breast
4.1.3 Colorectal
4.1.4 Prostate
4.1.5 Cervical
4.1.6 Others
4.2 Global Cancer Diagnostics Device Market Size by Application
4.2.1 Global Cancer Diagnostics Device Market Size Overview by Application (2018-2029)
4.2.2 Global Cancer Diagnostics Device Historic Market Size Review by Application (2018-2023)
4.2.3 Global Cancer Diagnostics Device Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Cancer Diagnostics Device Sales Breakdown by Application (2018-2023)
4.3.2 Europe Cancer Diagnostics Device Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Cancer Diagnostics Device Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Cancer Diagnostics Device Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Cancer Diagnostics Device Sales Breakdown by Application (2018-2023)
5 North America Cancer Diagnostics Device by Country
5.1 North America Cancer Diagnostics Device Historic Market Size by Country
5.1.1 North America Cancer Diagnostics Device Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Cancer Diagnostics Device Sales in Volume by Country (2018-2023)
5.1.3 North America Cancer Diagnostics Device Sales in Value by Country (2018-2023)
5.2 North America Cancer Diagnostics Device Forecasted Market Size by Country
5.2.1 North America Cancer Diagnostics Device Sales in Volume by Country (2024-2029)
5.2.2 North America Cancer Diagnostics Device Sales in Value by Country (2024-2029)
6 Europe Cancer Diagnostics Device by Country
6.1 Europe Cancer Diagnostics Device Historic Market Size by Country
6.1.1 Europe Cancer Diagnostics Device Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Cancer Diagnostics Device Sales in Volume by Country (2018-2023)
6.1.3 Europe Cancer Diagnostics Device Sales in Value by Country (2018-2023)
6.2 Europe Cancer Diagnostics Device Forecasted Market Size by Country
6.2.1 Europe Cancer Diagnostics Device Sales in Volume by Country (2024-2029)
6.2.2 Europe Cancer Diagnostics Device Sales in Value by Country (2024-2029)
7 Asia-Pacific Cancer Diagnostics Device by Region
7.1 Asia-Pacific Cancer Diagnostics Device Historic Market Size by Region
7.1.1 Asia-Pacific Cancer Diagnostics Device Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Cancer Diagnostics Device Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Cancer Diagnostics Device Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Cancer Diagnostics Device Forecasted Market Size by Region
7.2.1 Asia-Pacific Cancer Diagnostics Device Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Cancer Diagnostics Device Sales in Value by Region (2024-2029)
8 Latin America Cancer Diagnostics Device by Country
8.1 Latin America Cancer Diagnostics Device Historic Market Size by Country
8.1.1 Latin America Cancer Diagnostics Device Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Cancer Diagnostics Device Sales in Volume by Country (2018-2023)
8.1.3 Latin America Cancer Diagnostics Device Sales in Value by Country (2018-2023)
8.2 Latin America Cancer Diagnostics Device Forecasted Market Size by Country
8.2.1 Latin America Cancer Diagnostics Device Sales in Volume by Country (2024-2029)
8.2.2 Latin America Cancer Diagnostics Device Sales in Value by Country (2024-2029)
9 Middle East and Africa Cancer Diagnostics Device by Country
9.1 Middle East and Africa Cancer Diagnostics Device Historic Market Size by Country
9.1.1 Middle East and Africa Cancer Diagnostics Device Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Cancer Diagnostics Device Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Cancer Diagnostics Device Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Cancer Diagnostics Device Forecasted Market Size by Country
9.2.1 Middle East and Africa Cancer Diagnostics Device Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Cancer Diagnostics Device Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Abbott Diagnostics
10.1.1 Abbott Diagnostics Company Information
10.1.2 Abbott Diagnostics Introduction and Business Overview
10.1.3 Abbott Diagnostics Cancer Diagnostics Device Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Abbott Diagnostics Cancer Diagnostics Device Products Offered
10.1.5 Abbott Diagnostics Recent Development
10.2 Agilent Technologies
10.2.1 Agilent Technologies Company Information
10.2.2 Agilent Technologies Introduction and Business Overview
10.2.3 Agilent Technologies Cancer Diagnostics Device Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Agilent Technologies Cancer Diagnostics Device Products Offered
10.2.5 Agilent Technologies Recent Development
10.3 BD
10.3.1 BD Company Information
10.3.2 BD Introduction and Business Overview
10.3.3 BD Cancer Diagnostics Device Sales, Revenue and Gross Margin (2018-2023)
10.3.4 BD Cancer Diagnostics Device Products Offered
10.3.5 BD Recent Development
10.4 bioMérieux
10.4.1 bioMérieux Company Information
10.4.2 bioMérieux Introduction and Business Overview
10.4.3 bioMérieux Cancer Diagnostics Device Sales, Revenue and Gross Margin (2018-2023)
10.4.4 bioMérieux Cancer Diagnostics Device Products Offered
10.4.5 bioMérieux Recent Development
10.5 Qiagen
10.5.1 Qiagen Company Information
10.5.2 Qiagen Introduction and Business Overview
10.5.3 Qiagen Cancer Diagnostics Device Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Qiagen Cancer Diagnostics Device Products Offered
10.5.5 Qiagen Recent Development
10.6 Roche Diagnostics
10.6.1 Roche Diagnostics Company Information
10.6.2 Roche Diagnostics Introduction and Business Overview
10.6.3 Roche Diagnostics Cancer Diagnostics Device Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Roche Diagnostics Cancer Diagnostics Device Products Offered
10.6.5 Roche Diagnostics Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Cancer Diagnostics Device Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Cancer Diagnostics Device Industrial Chain Analysis
11.4 Cancer Diagnostics Device Market Dynamics
11.4.1 Cancer Diagnostics Device Industry Trends
11.4.2 Cancer Diagnostics Device Market Drivers
11.4.3 Cancer Diagnostics Device Market Challenges
11.4.4 Cancer Diagnostics Device Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Cancer Diagnostics Device Distributors
12.3 Cancer Diagnostics Device Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
